Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher? The Motley Fool 20:58 Mon, 10 Aug
Moderna and Merck’s Personalized mRNA Cancer Vaccine Succeeds in Landmark Phase 3 Melanoma Trial The Red Ferret Journal 4d Merck and Co Moderna Pharma All sources
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe? The Economic Times 1d Symbiotec Pharmalab Pharma All sources
Skyclarys approved: HSE to fund Friedreich’s Ataxia drug for Irish patients JOE.ie 21h Biogen Biotech Pharma All sources
STAT Plus: Inside Moderna and Merck’s cancer vaccine triumph STAT 2d Moderna Biotech Pharma All sources
